Grace Therapeutics, Inc. (GRCE)
Operating Income
-$25.69M
TTM · Period ending: · USD
GRCE Operating Income
Latest reported-$25.69Mperiod ending
Latest reported-$25.69Mperiod ending
GRCE Operating Income (-$1.20M → -$25.69M)
Annual operating income
High-resolution chart · PNG
GRCE operating income history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income (USD) |
|---|---|
| -11,077,000 | |
| -23,752,730 | |
| -17,440,292 | |
| -70,541,289 | |
| -19,478,039 | |
| -25,911,738 | |
| -48,831,870 | |
| -34,406,000 | |
| -15,251,546 | |
| -10,522,125 | |
| -9,827,589 | |
| -9,906,727 | |
| -9,706,204 | |
| -6,817,810 | |
| -6,550,639 | |
| -3,083,919 | |
| -1,538,732 | |
| -1,195,074 |